These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 823192

  • 1. An ergot alkaloid preparation (Hydergine) in the treatment of dementia: critical review of the clinical literature.
    Hughes JR, Williams JG, Currier RD.
    J Am Geriatr Soc; 1976 Nov; 24(11):490-7. PubMed ID: 823192
    [Abstract] [Full Text] [Related]

  • 2. An ergot alkaloid preparation (hydergine) versus placebo for treatment of symptoms of cerebrovascular insufficiency: double-blind study.
    Jennings WG.
    J Am Geriatr Soc; 1972 Aug; 20(8):407-12. PubMed ID: 4626496
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A double-blind evaluation of 'Hydergine' and placebo in the treatment of patients with organic brain syndrome and cerebral arteriosclerosis in a nursing home.
    Thibault A.
    Curr Med Res Opin; 1974 Aug; 2(8):482-7. PubMed ID: 4217240
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A clinical trial comparing 'Hydergine' with placebo in the treatment of cerebrovascular insufficiency in elderly patients.
    McConnachie RW.
    Curr Med Res Opin; 1973 Aug; 1(8):463-8. PubMed ID: 4204090
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Letter: Double blind study of hydergine in aged patients].
    Paux G, Boismare F, Delaunay P.
    Nouv Presse Med; 1975 Oct 18; 4(35):2529. PubMed ID: 812060
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. An ergot alkaloid preparation (Hydergine) versus papaverine in treating common complaints of the aged: double-blind study.
    Bazo AJ.
    J Am Geriatr Soc; 1973 Feb 18; 21(2):63-71. PubMed ID: 4631704
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [On the encephalotrophic action of hydergine. Clinical study].
    Garagnani Sciarretta B, Rimondini S, Martelli A.
    Minerva Med; 1974 Aug 29; 65(59):3090-8. PubMed ID: 4214406
    [No Abstract] [Full Text] [Related]

  • 13. Double-blind clinical and psychologic study of ergoloid mesylates (Hydergine) in subjects with senile mental deterioration.
    van Loveren-Huyben CM, Engelaar HF, Hermans MB, van der Bom JA, Leering C, Munnichs JM.
    J Am Geriatr Soc; 1984 Aug 29; 32(8):584-8. PubMed ID: 6379022
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Therapeutic findings in 23 geriatric cases treated with hydergine (clinical note)].
    Tessler D.
    Hospital (Rio J); 1970 Jul 29; 78(1):267-70. PubMed ID: 4991827
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A double-blind investigation of hydergine in the treatment of cerebrovascular insufficiency in the elderly.
    Rao DB, Norris JR.
    Johns Hopkins Med J; 1972 May 29; 130(5):317-24. PubMed ID: 4622959
    [No Abstract] [Full Text] [Related]

  • 20. [Hydergine in the treatment of cerebral circulatory disorders, including arteriosclerosis (author's transl)].
    Lozeron H.
    Schweiz Rundsch Med Prax; 1974 May 28; 63(21):660-5. PubMed ID: 4208744
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.